Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.

Who May Be Eligible (Plain English)

Who May Qualify: - A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription. - Stable medication for at least four weeks (no change in dopaminergic therapy). - The ability to walk at least 200 metres without stopping. - Minimum age: 18 years - Sufficient knowledge of German to understand the study information and complete the questionnaires. - Written willing to sign a consent form form Who Should NOT Join This Trial: - Atypical or secondary Parkinsonism - Sensory disturbances in the feet (e.g. polyneuropathy). - Other neurological, orthopaedic or internal medical conditions that significantly affect walking - Cognitive impairments that interfere with understanding the study information or following instructions Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion criteria: * A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription. * Stable medication for at least four weeks (no change in dopaminergic therapy). * The ability to walk at least 200 metres without stopping. * Minimum age: 18 years * Sufficient knowledge of German to understand the study information and complete the questionnaires. * Written informed consent form Exclusion criteria: * Atypical or secondary Parkinsonism * Sensory disturbances in the feet (e.g. polyneuropathy). * Other neurological, orthopaedic or internal medical conditions that significantly affect walking * Cognitive impairments that interfere with understanding the study information or following instructions

Treatments Being Tested

DEVICE

Vibrotactile feedback during walking

NUSHU smart shoes give real time gait feedback during walking.

Locations (1)

Magnes AG
Zurich, Canton of Zurich, Switzerland